Literature DB >> 20224596

FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion.

Naoki Suzuki1, Masashi Aoki, Hitoshi Warita, Masaaki Kato, Hideki Mizuno, Naoko Shimakura, Tetsuya Akiyama, Hirokazu Furuya, Toshihiro Hokonohara, Akiko Iwaki, Shinji Togashi, Hidehiko Konno, Yasuto Itoyama.   

Abstract

Mutations in the fused in sarcoma (FUS, also known as translated in liposarcoma) gene have been recently discovered to be associated with familial amyotrophic lateral sclerosis (FALS) in African, European and American populations. In a Japanese family with FALS, we found the R521C FUS mutation, which has been reported to be found in various ethnic backgrounds. The family history revealed 23 patients with FALS among 46 family members, suggesting a 100% penetrance rate. They developed muscle weakness at an average age of 35.3 years, followed by dysarthria, dysphagia, spasticity and muscle atrophy. The average age of death was 37.2 years. Neuropathological examination of the index case revealed remarkable atrophy of the brainstem tegmentum characterized by cytoplasmic basophilic inclusion bodies in the neurons of the brainstem. We screened 40 FALS families in Japan and found 4 mutations (S513P, K510E, R514S, H517P) in exon 14 and 15 of FUS. Even in Asian races, FALS with FUS mutations may have the common characteristics of early onset, rapid progress and high penetrance rate, although in patients with the S513P mutation it was late-onset. Degeneration in multiple systems and cytoplasmic basophilic inclusion bodies were found in the autopsied cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224596     DOI: 10.1038/jhg.2010.16

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  24 in total

1.  Lower motor neuron disease caused by a novel FUS/TLS gene frameshift mutation.

Authors:  Makoto Hara; Masayuki Minami; Satoshi Kamei; Naoki Suzuki; Masaaki Kato; Masashi Aoki
Journal:  J Neurol       Date:  2012-05-23       Impact factor: 4.849

Review 2.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

Review 3.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

4.  Combined FDG and raclopride PET study in a case of ALS with the R521C FUS gene mutation.

Authors:  Satoshi Kono; Yasuomi Ouchi; Tatsuhiro Terada; Makiko Suzuki; Shunsuke Yagi; Hiroaki Miyajima
Journal:  J Neurol       Date:  2011-07-15       Impact factor: 4.849

5.  Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.

Authors:  Ian R A Mackenzie; Olaf Ansorge; Michael Strong; Juan Bilbao; Lorne Zinman; Lee-Cyn Ang; Matt Baker; Heather Stewart; Andrew Eisen; Rosa Rademakers; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2011-05-21       Impact factor: 17.088

Review 6.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

Review 7.  Fused in Sarcoma Neuropathology in Neurodegenerative Disease.

Authors:  Ian R A Mackenzie; Manuela Neumann
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 8.  Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Authors:  Ian R A Mackenzie; Manuela Neumann; Nigel J Cairns; David G Munoz; Adrian M Isaacs
Journal:  J Mol Neurosci       Date:  2011-05-21       Impact factor: 3.444

9.  Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis.

Authors:  Takao Nomura; Shoji Watanabe; Kumi Kaneko; Koji Yamanaka; Nobuyuki Nukina; Yoshiaki Furukawa
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

10.  Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.

Authors:  Alexandra Arenas; Jing Chen; Lisha Kuang; Kelly R Barnett; Edward J Kasarskis; Jozsef Gal; Haining Zhu
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.